An observational study to determine thromboembolism prophylaxis in cancer patients
Not Applicable
Completed
- Conditions
- Health Condition 1: I824- Acute embolism and thrombosis of deep veins of lower extremityHealth Condition 2: null- Thromboembolism prophylaxis in oncology patients who are undergoing abdominal or pelvic surgery
- Registration Number
- CTRI/2013/05/003617
- Lead Sponsor
- SanofiSynthelabo India Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 295
Inclusion Criteria
1. Male or female patient >= 18 years of age
2. Patients hospitalized for surgery of abdominal or pelvic (such as colon, rectum, stomach, liver, pancreas, prostate, urinary bladder, uterus and ovarian) malignant tumor
3. Patients who have undergone surgery for this malignant tumor in the last 2 days
4. Signed Informed consent
Exclusion Criteria
1.Patient with a life expectancy of less than 1 month
2.Patient currently participating in a clinical trial
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of oncology patient undergoing surgery for the malignant abdominal or pelvic tumor who are given thromboprophylaixs <br/ ><br>Timepoint: not applicable <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1. Proportion of patients who develop symptomatic DVT at the end of 30 days <br/ ><br>2. To evaluate the profile of patients who are admitted (in terms of: Age, gender, type of malignant tumor, stage of malignancy, type of admitting hospital). The profile of the patients will be analyzed for thromboprophylaxis given or not and if the patient develops symptomatic DVT or not. <br/ ><br>3. Reasons for not administering thromboprophylaxis <br/ ><br>Timepoint: 30 days